High-dose cytosine arabinoside therapy for refractory leukemia.
D003561:Cytarabine / Q000009:adverse effects*; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D007938:Leukemia / Q000150:complications*; D065227:Transfusion Reaction
D003561:Cytarabine